Intelligence · Clinical Pipeline
AXIM Biotechnologies Pipeline
All ClinicalTrials.gov programs at AXIM Biotechnologies — phase, modality, and trial IDs.
- Programs
- 3
Quick answer
AXIM Biotechnologies has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Fludarabine phosphate 25 mg/ml Concentrate for Solution for Injection or Infusion
AXIM BIOTECHNOLOGIES, INC.
B-cell Acute Lymphoblastic Leukemia
1 trial -
IVEMEND 150 mg powder for solution for infusion, Aprepitant Placebo Tablet, Aprepitant Teva 80 mg, harde capsules, NaCl I.V.
AXIM BIOTECHNOLOGIES, INC.
Delayed chemotherapy induced nausea and vomiting (CINV)
1 trial -
Targocid 400mg powder for solution for injection/infusion or oral solution, Targocid 400mg powder for solution for injection/infusion or oral solution, Targocid 400mg powder for solution for injection/infusion or oral solution, Targocid 400mg powder for solution for injection/infusion or oral solution
AXIM BIOTECHNOLOGIES, INC.
Acute myeloid leukemia
1 trial
Frequently asked questions
How many pipeline programs does AXIM Biotechnologies have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs